A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients

Mise à jour : Il y a 4 ans
Référence : NCT00876044

Femme et Homme

Extrait

The primary objective of this study is to evaluate the effects of aflibercept on the QTc interval in cancer patients. Secondary objectives are to evaluate the effects of aflibercept on other electrocardiogram (ECG) parameters, clinical safety and pharmakokinetic (PK) parameters.


Critère d'inclusion

  • Cancer


Liens